Justification
J&A to extend Period or Performance for procurement of Inmazeb
JOFOC-REG-1
Office of Assistant Secretary for Preparedness and Response, Barda - Aspr / Daappo / Barda DCMA. Research and Development in Biotechnology (except Nanobiotechnology).
Awarded
Regeneron Pharmaceuticals Inc.
$280,503,480.24 obligated so far on USAspending, September 25, 2026, contract HHSO100201700016C
Get the next one like this from Office of Assistant Secretary for Preparedness and Response by email, the day it is posted.Find my opportunities
This one was awarded in 2026
15 like it are open now in research and development in biotechnology (except nanobiotechnology)
- Development/Production - Kidney GEC-Specific AAV Vector
Department of Veterans Affairs, Rpo East
Sources soughtNAICS 541714Columbia, MO36C24E27Q0009Closes in 11 daysNov 4 - AMPLICON SEQUENCING SERVICES
US Geological Survey, Ofc of Acquisition Grants-Denver
SolicitationNAICS 541714Location not published140G0226Q0047Closes in 12 daysNov 5 - High-throughput Unmasking of Biological Interactomes with Binding Landscape Emulators (HUBBLE)
Defense Advanced Research Projects Agency, Def Advanced Research Projects Agcy
SolicitationNAICS 541714Anywhere in the USDARPA-PA-27-01Closes in 13 daysNov 5
All 15 open in research and development in biotechnology (except nanobiotechnology)
Description
As published on SAM.gov.
J&A to extend Period or Performance for procurement of Inmazeb.
Attachments
Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Regeneron Pharmaceuticals Inc.
- UEI
- N3F9MH7E6HD6
- CAGE
- 544P9
- Vendor location
- Tarrytown, NY
- Contract
- HHSO100201700016C, definitive contract
- Obligated
- $280,503,480.24, current value $973,560,407, potential $1,036,922,155
- Actions
- 4 between December 6, 2024 and September 25, 2026
- Competition
- Full and Open Competition, 2 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- No Cost Mod to Revise the Contract Sections: Article B.2.1., Article C.1., Article F.4, , Article G.4. and the Statement of Work.
- Match
- award number HHSO100201700016C equals the contract number; same awarding office 75A501 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
October 10, 2026
Justification
SAM.gov, notice daa1e8e40787461fa8e150fc993944d8
1 revisions on SAM
- October 10, 2026: publish, justification
Points of contact
- Yifan Yangyifan.yang@hhs.gov
- Jonathan GonzalezJonathan.Gonzalez@hhs.gov